Antimicrobial resistance and COVID-19: Intersections and implications

GM Knight, RE Glover, CF McQuaid, ID Olaru… - Elife, 2021 - elifesciences.org
Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR)
was among the top priorities for global public health. Already a complex challenge, AMR …

Coronavirus disease 2019 treatment: a review of early and emerging options

EK McCreary, JM Pogue - Open forum infectious diseases, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …

Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome

T Bardi, V Pintado, M Gomez-Rojo… - European Journal of …, 2021 - Springer
Bacterial and fungal co-infection has been reported in patients with COVID-19, but there is
limited experience on these infections in critically ill patients. The objective of this study was …

Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge

P Nori, K Cowman, V Chen, R Bartash… - Infection Control & …, 2021 - cambridge.org
We observed bacterial or fungal coinfections in COVID-19 patients admitted between March
1 and April 18, 2020 (152 of 4,267, 3.6%). Among these patients, mortality was 57%; 74 …

Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a multi-hospital cohort …

VM Vaughn, TN Gandhi, LA Petty… - Clinical infectious …, 2021 - academic.oup.com
Background Antibacterials may be initiated out of concern for bacterial coinfection in
coronavirus disease 2019 (COVID-19). We determined prevalence and predictors of empiric …

[HTML][HTML] Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?

S Ghosh, C Bornman, MM Zafer - Journal of infection and public health, 2021 - Elsevier
Antimicrobial resistance (AMR) continues to exert a substantial toll on the global health and
world economy and is now expected to be hidden by COVID-19 for a while. The wrong …

Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship

K Rothe, S Feihl, J Schneider, F Wallnöfer… - European Journal of …, 2021 - Springer
Abstract The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. Bacterial co-infections are …

Antibiotic prescription during the COVID-19 pandemic: a biphasic pattern

G Abelenda-Alonso, A Padullés… - Infection Control & …, 2020 - cambridge.org
To the Editor—The COVID-19 pandemic, caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a public health problem of historic dimensions. However …

Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID

J Calderón-Parra, A Muiño-Miguez… - PloS one, 2021 - journals.plos.org
Background Most patients with COVID-19 receive antibiotics despite the fact that bacterial co-
infections are rare. This can lead to increased complications, including antibacterial …

Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?

E Pelfrene, R Botgros, M Cavaleri - Antimicrobial resistance & infection …, 2021 - Springer
Background Antimicrobial resistance (AMR) is a growing global problem to which the
ongoing COVID-19 pandemic may further contribute. With resources deployed away from …